VANCOUVER, BC, June 12, 2026 /CNW/ - The following issues have been halted by CIRO
Company: Highcliff Metals Corp.TSX-Venture Symbol: HCM.H All Issues: YesReason: Improper...
Bitmine's Board of Directors declares initial cash dividends on the Company's 9.50% Series A Perpetual Preferred StockSeries A Preferred Stock approved for listing on...
NEW YORK, June 12, 2026 /PRNewswire/ -- M3-Brigade Acquisition V Corp. (Nasdaq: MBAV) (the "Company"), a special purpose acquisition company, today announced that it...
ATLANTA, June 12, 2026 /PRNewswire/ -- The Southeast Energy Exchange Market will hold its board meeting and annual meeting of participants and stakeholders on...
STATEN ISLAND, New York, June 12, 2026 (GLOBE NEWSWIRE) -- Coffee Holding Co., Inc. (Nasdaq: JVA) (the “Company,” “our” or “we”) announced its operating results for the fiscal quarter ended April 30, 2026.
NEW CANAAN, Conn., June 12, 2026 (GLOBE NEWSWIRE) -- NewLake Capital Partners, Inc. (OTCQX: NLCP) (“The Company” or “NewLake”), a leading provider of real estate capital to state-licensed cannabis operators, today announced that its board of directors has approved its second quarter 2026 cash dividend of $0.43 per share of common stock. The dividend is equivalent to an annualized dividend of $1.72 per common share and is payable on July 15, 2026, to common stockholders of record at the close of business on June 30, 2026.
ATLANTA, June 12, 2026 /PRNewswire/ -- Invesco Mortgage Capital Inc. (NYSE: IVR) (the "Company") today announced that the Company declared a cash dividend of...
FREDERICK, Md., June 12, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a late clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the granting of an inducement award to one new employee. On June 8, 2026, the Company issued to this employee an option to purchase an aggregate of 6,100 shares of the Company’s common stock with an exercise price of $5.86, the closing trading price of the Company’s common stock on the Nasdaq Global Market on the date of grant. The option was granted pursuant to the Company’s Amended and Restated 2018 Employment Inducement Incentive Award Plan and was approved by the Company’s board of directors. The option vests as to 25% on June 8, 2027, and then in thirty-six substantially equal monthly installments thereafter such that the option will be fully vested on June 8, 2030. The option has a ten-year term. The option was granted under Rule 5635(c)(4) of the Nasdaq Listing Rules as an inducement material to the employee’s entry into employment with the Company.
EMERYVILLE, Calif., June 12, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that on June 9, 2026, the compensation committee of the Company’s board of directors granted seven new non-executive employees 66,900 Restricted Stock Units (RSUs). The RSUs were granted pursuant to the Company’s 2025 Employment Inducement Award Plan, as amended, under Rule 5635(c)(4) of The Nasdaq Global Market for equity grants to induce new employees to enter into employment with the Company.
Live music on multiple stages, a Family Fun Zone, live mural, drum circles, and more across Downtown Ventura.VENTURA, Calif., June 12, 2026 /PRNewswire/ --...
LAKE FOREST, Calif., June 12, 2026 /PRNewswire/ -- Zelus, a global leader in innovative athletic equipment and an Amazon bestseller in wearable resistance, has officially...
LAKE FOREST, Calif., June 12, 2026 /PRNewswire/ -- Zelus, a global leader in innovative athletic equipment and an Amazon bestseller in wearable resistance, has officially...